Omkar Pharmachem Ltd

BSE: 532167

17

total announcements

OMKARPH.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 19 Nov 2026

Market Cap

₹7 Cr

P/E (TTM)

0.3

EPS (TTM)

₹26.94

52W Low

₹5.66

52W High

₹29.74

Dividend Yield

0.00%

Beta

0.23

Price / Book

0.2

Revenue (TTM)

₹42,00,000.00

Gross Margin

49.83%

Operating Margin

26.60%

BSEResultResults4d ago

Omkar Pharmachem Ltd

Dear Sir/Ma''am, Please find Unaudited Financial Results for the Quarter and Half year ended 30.09.2026

Omkar Pharmachem Ltd has released unaudited financial results for the quarter and half year ended 30th September, 2026. The results show a net profit of Rs. 0.39 lakhs for the quarter and Rs. 7.74 lakhs for the half year. The company's total assets stood at Rs. 3667.59 lakhs as of 30th September, 2026, with total equity at Rs. 3663.36 lakhs. The company's cash and cash equivalents stood at Rs. 16.47 lakhs as of 30th September, 2026.

Read more →📎 1 attachment
BSEBoard MeetingResults4d ago

Omkar Pharmachem Ltd

Dear Sir/Ma''am, Please find Qutcome of the Board Meeting held on 14 November, 2026 for approval of Unaudited Financial Results of the Company along with Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report for the Quarter and half year ended on 30 September, 2026.

Omkar Pharmachem Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a net profit of Rs. 0.39 lakhs and a loss of Rs. 1.00 lakhs for the quarter. The company's total assets stood at Rs. 3667.59 lakhs and total liabilities at Rs. 423 lakhs.

Read more →📎 1 attachment
BSEBoard MeetingResults4 Nov 2026

Omkar Pharmachem Ltd

Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Omkar Pharmachem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Financial result for the quarter and half year ended on September 30, 2026 along with Limited Review Report thereof.

Omkar Pharmachem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 to consider and approve Unaudited Financial result for the quarter and half year ended on September 30, 2026 along with Limited Review Report thereof.

Read more →📎 1 attachment
BSEAGM/EGMMgmt Change30 Sept 2026

Omkar Pharmachem Ltd

Dear Sir/Ma''am, Please find Proceeding of 31st AGM & Reporting Under Reg. 30 of SEBI(LODR) Regulation, 2015

Omkar Pharmachem Ltd held its 31st Annual General Meeting (AGM) on September 30, 2026, at Hotel Kanak, Ahmedabad. The meeting was chaired by Managing Director Bhawani S Goyal. The company received and adopted its audited financial statements for the year ended March 31, 2026, and appointed a new director. The meeting also considered and approved material related party transactions.

Read more →📎 1 attachment
BSEInsider Trading / SAST26 Sept 2026

Omkar Pharmachem Ltd

Dear Sir, Please find Intimation of Closure of Trading Window.

Omkar Pharmachem Ltd has announced the closure of its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half-year ended September 30, 2026.

Read more →📎 1 attachment
BSECompany Update3 Sept 2026

Omkar Pharmachem Ltd

Dear Sir, Please find Newspaper Publication under Reg 47 of SEBI (LODR) Regulations, 2015 regarding the 31st Annual General Meeting of the Company.

Omkar Pharmachem Ltd has announced the submission of a newspaper publication under Regulation 47 of SEBI (LODR) Regulations, 2015 regarding the 31st Annual General Meeting of the Company. The AGM will be held on September 30, 2026, and the company has also made available the Annual Report along with the Notice convening the AGM on its website.

Read more →📎 1 attachment
BSEAGM/EGMMgmt Change2 Sept 2026

Omkar Pharmachem Ltd

Pursuant to Regulation 30 of SEBI( Listing Obligations and Disclosures requirements) Regulations, 2015, Please find attached herewith the Notice convening 31st Annual General Meeting of the Company

Omkar Pharmachem Ltd has announced its 31st Annual General Meeting (AGM) to be held on September 30, 2026, to consider various business, including the appointment of a director, approval of related party transactions, and adoption of audited financial statements.

Read more →📎 1 attachment
BSEResultResults13 Aug 2026

Omkar Pharmachem Ltd

Dear Sir, Pursuant to provisions of Reg. 33 of SEBI (LODR)Regulations, 2015, please find Unaudited Financial Results for the Quarter ended on 30.06.2026

Omkar Pharmachem Ltd has released its unaudited financial results for the quarter ended June 30, 2026, with a net loss of Rs. 1.00 lakhs. The company's revenue from operations was Rs. 9.00 lakhs, with other operating income of Rs. 9.00 lakhs. The company's expenses were Rs. 10.00 lakhs, resulting in a net loss of Rs. 1.00 lakhs. The earnings per share (EPS) before and after extraordinary items was Rs. 0.0099.

Read more →📎 1 attachment
BSEBoard MeetingResults6 Aug 2026

Omkar Pharmachem Ltd

Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Unaudited Financial result ....

Omkar Pharmachem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 to consider and approve Unaudited Financial result for the quarter ended on June 30, 2026 along with Limited Review Report thereof.

Read more →📎 1 attachment